EP3041476
BARKSTERAEFNASAMSETNING Í TÖFLUFORMI, SEM LEYSIST UPP Í MUNNI, VIÐ EÓSÍNFÍKINNI VÉLINDABÓLGU
Status:
EP Einkaleyfi fallið úr gildiEP appl. date:
5.9.2014EP published:
6.11.2019EP application number:
14842811.3
EP translation filed:
9.1.2020Grant published:
15.2.2020EPO information:
European Patent Register
Max expiry date:
4.9.2034Expiry date:
4.9.2024
Title:
CORTICOSTEROID CONTAINING ORALLY DISINTEGRATING TABLET COMPOSITIONS FOR EOSINOPHILIC ESOPHAGITIS
Timeline
Today
5.9.2014EP application
6.11.2019EP Publication
9.1.2020Translation submitted
15.2.2020Registration published
4.9.2024Expires
Owner
Name:
Adare Pharmaceuticals US, L.P.Address:
1200 Lenox Drive, Suite 100, Lawrenceville, NJ 08648, US
Inventor
Name:
GOSSELIN, Michael, A.Address:
Springboro, OH, US
Name:
LAI, Jin-WangAddress:
Springboro, OH, US
Name:
VENKATESH, Gopi,M.Address:
Vandalia, OH, US
Agent
Name:
Árnason Faktor ehf.Address:
Guðríðarstíg 2-4, 113, Reykjavík,
Priority
Number:
201361874450 PDate:
6.9.2013Country:
US
Classification
Categories:
A61K 9/20, A61K 31/56
Annual fees
Number
Paid
Expires
Payer
Number: 7
Paid: 18.8.2020
Expires: 4.9.2021
Payer: Sigurjónsson & Thor ehf.
Number: 8
Paid: 18.8.2021
Expires: 4.9.2022
Payer: Sigurjónsson & Thor ehf.
Number: 9
Paid: 19.8.2022
Expires: 4.9.2023
Payer: Patice ehf.
Number: 10
Paid: 28.8.2023
Expires: 4.9.2024
Payer: Árnason Faktor ehf.